| Sanofi | Rheumatoid arthritis | PDY17062 |
| Novartis Hungária Kft. | Renal Impairment | CLOU064A2103 |
| Reneo Pharma Ltd. | Hepatic Impairment | REN001-108 |
| Deciphera Pharmaceuticals, LLC. | Hepatic Impairment | DCC-3014-01-004 |
| Idorsia Pharmaceuticals Ltd | Hepatic Impairment | ID-064-106 |
| Telios Pharma, Inc. | Hepatic Impairment | TL-895, CA33402 |
| Prestige Biopharma Limited | Healthy | SOLOMON-I |
| BioVersys AG | Drug-Drug Interaction | BV100-007 |
| CRU Hungary Kft. | Volunteer | Pre-Screen 1 |
| CRU Hungary Kft. | Other | Feas-001 |
| Dr. Falk Pharma GmbH | Hepatic Impairment | NUT-009/BIO |
| Xeno Biosciences | Healthy | XB22-001 |
| Neurotherapia Inc | Alzheimer Disease | NTRX-07-C102 |
| Novartis Hungária Kft. | Hepatic Impairment | LOU064A2101 |
| Boehringer Ingelheim | Hepatic Impairment | 1404-0010 |
| Umecrine Cognition AB | Hepatic Impairment | UCAB-CT-05 |
| Xeno Biosciences | Healthy | XB22-001 |
| BioVersys AG | Hepatic Impairment | BV100-008 |
| Neurotherapia Inc | Alzheimer Disease | NTRX-07-C102 |
| BioVersys AG | Drug-Drug Interaction | BV100-005 |
| Adiposs SA | Healthy | ImageBAT |
| Janssen-Cilag International N.V. | Rheumatoid arthritis | 67484703ARA1001 |
| Astrocytes Pharmaceuticals Inc. | Healthy | AST-004-1-02 |
| Takeda Global Research | Hepatic Impairment | TAK-935-1010 |
| BioVersys AG | Renal Impairment | BV100-003 |
| AstraZeneca | Asthma | D6830C00001 |
| NewAmsterdam Pharma BV | Lipidaemia | TA-8995-304 |
| IONIS PHARMACEUTICALS, INC. | Hypertriglyceridemia | ISIS678354-CS5 |
| Amgen Kft. | Cardiovascular outcomes studies | 20210057 |
| AstraZeneca | Other respiratory | D9180C00003 |
| AstraZeneca | COPD | D3251C00014 |
| AstraZeneca | Asthma | D5982C00007N |
| Opiant Pharmaceuticals | Alcohol addiction | OPNT002-AUD-001 |
| Amgen Kft. | Hypercholesterolemia | 20170625 |
| AbbVie Inc. | Psoriatic Arthritis | M15-998 |
| Valbiotis S.A. | Diabetes/ obesity in diabetes | PEC16075 |
| Eli Lilly and Compary | Rheumatoid arthritis | I4V-MC-JAJA |
| American Regent, Inc. | Other cardiovascular | 1VIT15043 |
| Pfizer Inc. | Dermatitis | B7451015 |
| AbbVie Inc. | Rheumatoid arthritis | MTX-IR M14-465 |
| AbbVie Inc. | Rheumatoid arthritis | MTX-native M13-545 |
| BioVersys AG | Renal Impairment | BV-100_RI |
| Mycovia Pharmaceuticals, Inc. | Hepatic Impairment | MT-VT-1161-CL-019 |
| MSD | Non Small Cell Lung Cancer | MK-7902-007-01 |
| Chiesi Farmaceutici S.p.A. | COPD | SGS_CHIESI |
| Eli Lilly and Compary | Rheumatoid arthritis | J1A-MC-KDAD |
| Chiesi Farmaceutici S.p.A. | COPD | SGS_CHIESI |
| Pfizer Inc. | Neisseria meningitidis | C3511001 |
| 89BIO | Hypertriglyceridemia | BIO89-100-221 |
| Pfizer Inc. | Diabetes/ obesity in diabetes | C3421005 |
| Affibody AB | Psoriatic Arthritis | ABY-035-202 |
| CRU Hungary Kft. | Sleeping Disorders | BORS/1-1/2020 |
| Boehringer Ingelheim | Palmoplantar Pustolosis | BI 1368-0016 |
| AbbVie Inc. | Crohn Disease | M14-430 |
| F. Hoffmann-La Roche AG | Hepatic Impairment | GP41174 |
| Galapagos NV | Hepatic Impairment | GLPG1690-CL-111 |
| MSD | Non Small Cell Lung Cancer | MK-3475-867 |
| MedDay Pharmaceuticals SA | Hepatic Impairment | OP107719.MED |
| MedDay Pharmaceuticals SA | Renal Impairment | OP107819.MED |
| Milestone Pharmaceuticals Inc. | Cardiovascular outcomes studies | NODE-303 |
| Estetra SPRL | Hepatic Impairment | MIT-Do001-C102 |
| Abivax | Rheumatoid arthritis | ABX464-301 |
| BiondVax Pharmaceuticals Ltd. | Influenza | BVX-010_2 |
| Bristol-Myers Squibb Company | Psoriatic Arthritis | IM011084 |
| AbbVie Inc. | Rheumatoid arthritis | M16-763 |
| Bristol-Myers Squibb Company | Hepatic Impairment | IM011-062 |
| KBP Biosciences Co. Ltd. | Hypertension | KBP-5074-2-001 |
| Summit (Oxford) Limited | Clostridium | SMT19969/C004 |
| Pfizer Inc. | Dermatitis | B7931022 |
| MSD | Non Small Cell Lung Cancer | MK-7902-007-01 |
| AbbVie Inc. | Rheumatoid arthritis | M16-560 |
| Umecrine Cognition AB | Hepatic Impairment | UCAB-CT-02 |
| Amgen Kft. | Dermatitis | 20170755 |
| AbbVie Inc. | Rheumatoid arthritis | M16-063 |
| AbbVie Inc. | Non Small Cell Lung Cancer | M14-239 |
| UCB Pharma Ltd | Psoriasis | PS0014 |
| BIAL | Hepatic Impairment | BIA-51058-113 |
| BIAL | Renal Impairment | BIA-51058-114 |
| AstraZeneca | Asthma | D3741C00007 |
| AstraZeneca | Cardiovascular outcomes studies | D169CC00001 |
| AstraZeneca | Other cardiovascular | D9484C00001 |
| AbbVie Inc. | Crohn Disease | M14-430 |
| AstraZeneca | Asthma | D3741C00007 |
| Avanir Pharmaceuticals Inc. | Alzheimer Disease | 17-AVP-786-305 |
| Basilea Pharmaceutica International Ltd | Dermatitis | BPR-CS-008 |
| CSL Behring GmBH | Acute Coronary Syndrome | CSL12_3001 |
| Bristol-Myers Squibb Company | Renal Impairment | MB130065 |
| Mitshubishi Tanabe Pharma | Hepatic Impairment | MCI-186-E05 |
| MSD | Chronic cough | MK 7264-027 |
| MSD | Chronic cough | MK 7264-030 |
| Pfizer Inc. | Dermatitis | B7451012 |
| BiondVax Pharmaceuticals Ltd. | Influenza | BVX-010 |
| Pfizer Inc. | Non Small Cell Lung Cancer | B991023 |
| Pfizer Inc. | Non Small Cell Lung Cancer | B9991025 |
| Chiesi Farmaceutici S.p.A. | COPD | CLI-05993BA102 |
| AbbVie Inc. | Crohn Disease | M14-431 |
| AbbVie Inc. | Crohn Disease | M14-433 |
| AstraZeneca | Diabetes/ obesity in diabetes | D5670C00007 |
| Galapagos NV | Dermatitis | MOR106-CL-201 |
| AbbVie Inc. | Small Cell Lung Cancer | M16-298 |
| UCB Pharma Ltd | Psoriasis | PS0013 |
| Bristol-Myers Squibb Company | Hepatic Impairment | CV013026 |
| Gan & Lee Pharmaceuticals | Diabetes/ obesity in diabetes | GL-GLAT1-3001 |
| Celgene International II Sàrl | Crohn Disease | RPC01-3202 |
| Proximagen Ltd. | Osteoarthritis | 167700-004CL |
| CERENIS Therapeutics | NASH | PROT-CER-209-CLIN-002 |
| CERENIS Therapeutics | NASH | PROT-CER-209-CLIN-002 |
| Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
| CRU Hungary Kft. | Healthy | CRU_RISKSCREEN |
| Proximagen Ltd. | Osteoarthritis | 167700-004CL |
| IONIS PHARMACEUTICALS, INC. | Diabetes/ obesity in diabetes | IS137CS2 |
| SHIELD Therapeutics | Anemia | ST10-01-304 |
| Novartis Hungária Kft. | Psoriatic Arthritis | CAIN457F2354 |
| CRU Hungary Kft. | Rheumatoid arthritis | RA_PRESCREEN |
| Ironwood Pharmaceuticals, Inc. | Gout | RDEA594-401 |
| CRU Hungary Kft. | COPD | HG_COPD |
| CRU Hungary Kft. | Other | CRU_Volunteer |
| AstraZeneca | COPD | D5970C00002 |
| Pfizer Inc. | Clostridium | B5091007 |
| Tricida Inc. | Nephropathy | TRCA-301 |
| Pfizer Inc. | Rheumatoid arthritis | A3921192 |
| Pfizer Inc. | Rheumatoid arthritis | B7984006 |
| Novimmun SA | Rheumatoid arthritis | AI-CF010b |
| Pfizer Inc. | Rheumatoid arthritis | B7921005 |
| AstraZeneca | Asthma | D2500C00003 |
| Pfizer Inc. | Hematology | A4091061 |
| GlaxoSmithKline Kft. | COPD | 2014N206201_00 |
| MSD | Non Small Cell Lung Cancer | MK-3475-715 |
| Relypsa Inc. | Hypertension | RLY5016-207 |
| AstraZeneca | COPD | PT009002-01 |
| Pfizer Inc. | Cardiovascular outcomes studies | B1521021 |
| AstraZeneca | Asthma | D3250C00038 |
| Biotest AG | Hematology | 992 |
| Biotest AG | Hematology | 992 |
| Meditop Pharmaceutical Ltd. | Other | KZ-PKP-092016 |
| Luitpold Pharmaceuticals Inc. | Hematology | 1VIT14039 |
| Amgen Kft. | Cardiovascular outcomes studies | 20130295 |
| Pfizer Inc. | Dermatitis | B7451006 |
| HAL Allergy B.V. | Allergic Rhinitis | PM/0041 |
| DalCore Pharma UK Ltd. | Cardiovascular outcomes studies | DAL-301 |
| Boehringer Ingelheim | Alzheimer Disease | BI 425809 |
| Polichem S.A. | pattern baldness | PM1541 |
| Mereo BioPharma 1 Ltd | COPD | MBCT206 |
| Novartis Hungária Kft. | Asthma | CQVM149B2301 |
| Pfizer Inc. | Low Back Pain | A4091059 |
| Amgen Kft. | Rheumatoid arthritis | 20130108 |
| Achaogen Inc. | Urinary infection | ACHN-490-009 |
| AbbVie Inc. | Rheumatoid arthritis | Biologics-IR M13-542 |
| Zavanta | Urinary infection | ZTI-01-200 |
| Motif BiosSciences Inc. | ABSSI | ICL-24-ABSSSI2 |
| Merck Sharp and Dohme | Diabetes/ obesity in diabetes | MK431-838 |
| Melinta Therapeutics | CABP | ML-3341-306 |
| IONIS PHARMACEUTICALS, INC. | Diabetes/ obesity in diabetes | 449884-CS3 |
| Chiesi Farmaceutici S.p.A. | COPD | CCD-06302AA1-01 |
| Servier Hungária Kft | Hematology | CL1-55746-001 |
| Pharmaxis | Cystic Fibrosis | DPM-CF-303 |
| Nabriva Therapeutics US, Inc. | CABP | NAB-BC-3781-3101 |
| Pearl Therapeutics, Inc. | COPD | PT010005 |
| Boehringer Ingelheim | Diabetes/ obesity in diabetes | BI 124572 |
| BioRasi LLC | Other | ZIN-130-1504 |
| Paratek Pharma, LLC, | CABP | PTK0796-CABP-1200 |
| F. Hoffmann-La Roche AG | COPD | WB29804 |
| Vectura Group Plc | Asthma | Vectura_VR475 |
| Paratek Pharma, LLC, | Dermatitis | PTK0796-ABSI-1108 |
| Novartis Hungária Kft. | Asthma | CQGE031B2204 |
| Merck Sharp and Dohme | Head and Neck Cancer | MK-3475-048 |
| Merck Sharp and Dohme | Head and Neck Cancer | MK-3475-040 |
| Boehringer Ingelheim | Embolic Stroke | BI1160.189 |
| AstraZeneca | Diabetes/ obesity in diabetes | D1689C0014 |
| Chiesi Farmaceutici S.p.A. | COPD | CCD-05993AA1-07 |
| GlaxoSmithKline Kft. | Diabetes/ obesity in diabetes | GLP116174 |
| Ablynx NV | Rheumatoid arthritis | ALX0061-C203 |
| Astellas Pharma Europe | Diabetes/diabetic nephropathy | 8232-CL-0004 |
| Astellas Pharma Europe | Diabetes/diabetic nephropathy | 8232-CL-0004 |
| AbbVie Inc. | Non Small Cell Lung Cancer | M11-089 |
| Ablynx NV | Rheumatoid arthritis | ALX0061-C202 |
| Ablynx NV | Rheumatoid arthritis | ALX-0061 C201 |
| Coherus Biosciences, Inc. | Rheumatoid arthritis | CHS-0214-02 |
| Janssen-Cilag International N.V. | Type 2 diabetes | 28431754DIA4003 |
| AstraZeneca | Asthma | 'BISE' D3250C00032 |
| AstraZeneca | Other | D4281C00001 |
| GlaxoSmithKline Kft. | COPD | CTT116853 |
| GW Pharma | Chronic Pain in Cancer | GWCA0999 |
| AbbVie Inc. | Non Small Cell Lung Cancer | M14-359 |
| IONIS PHARMACEUTICALS, INC. | Hyperlipidemia/ dyslipidemia | ISIS 304801-CS6 |
| Pfizer Inc. | Type 2 diabetes | B1521017 |
| Amgen Kft. | LDL-C abnormal lipid | 20130385 |
| Merck Sharp and Dohme | Non Small Cell Lung Cancer | MK-3475-010 |
| Merck Sharp and Dohme | Non Small Cell Lung Cancer | MK-3475-024 |
| Eli Lilly and Compary | Diabetes/ obesity in diabetes | H9X-MC-GBDX |
| Synta Pharmaceuticals Corp. | Non Small Cell Lung Cancer | Galaxy 2 / 9090-14 |
| Janssen-Cilag International N.V. | COPD | 49095397OPD2001 |
| AstraZeneca | Asthma | D589SC00001 |
| Synta Pharmaceuticals Corp. | Non Small Cell Lung Cancer | Galaxy 2 / 9090-14 |
| AstraZeneca | Asthma | D589SC00003 SYGMA2 |
| Nephrogenex Inc. | Diabetes/diabetic nephropathy | PYR-311 |
| AstraZeneca | Asthma | D2210C00007 |
| GlaxoSmithKline Kft. | COPD | DB2116961 |
| Chiesi Farmaceutici S.p.A. | COPD | CCD-1207-PR-0091 |
| Amgen Kft. | Osteoporosis | 20101217 |
| Chiesi Farmaceutici S.p.A. | COPD | CCD-1207-PR-0091 |
| GlaxoSmithKline Kft. | COPD | 201211 SGRQ |
| Chiesi Farmaceutici S.p.A. | COPD | CCD-1208-PR-0090 |
| Hanmi Pharmaceutical | Type 2 diabetes | HM-EXC-204 |
| GW Pharma | Chronic Pain in Cancer | GWCA1103 |
| AstraZeneca | COPD | D3251C00003 |
| GW Pharma | Chronic Pain in Cancer | GWCA1103 |
| MSD | Type 2 diabetes | MK-8835-001 |
| Pfizer Inc. | SPA | A3921119 |
| Shionogi Inc. | Opioid Indication Constipation | 1326V9235 |
| Omthera Pharmaceuticals | Hypertriglyceridemia | OM-EPA-011 |
| Janssen-Cilag International N.V. | Type 2 diabetes | 28431754DIA4003 |
| Hanmi Pharmaceutical | Type 2 diabetes | HM-EXC-203 |
| Ferring Pharmaceuticals | Constipation | 000081 |
| Aquinox | COPD | AQX-1125-202 |
| NEOVACS SA | Rheumatoid arthritis | TNF-K006 |
| Kowa Research Europe Ltd. | LDL-C abnormal lipid | K-877-201 |
| Ferring Pharmaceuticals | Constipation | 000080 |
| Janssen-Cilag International N.V. | Type 2 diabetes | 28431754-DIA-3011 |
| Develco Pharma | Opioid Indication Constipation | 0176/DEV |
| Develco Pharma | Opioid Indication Constipation | 0177/DEV |
| Amgen Kft. | LDL-C with CV outcome | 20110118 |
| Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-302 |
| Takeda Global Research | Diabetes/diabetic nephropathy | TAK-875-302 |
| Mitshubishi Tanabe Pharma | Diabetes/diabetic nephropathy | MT-3995-07 |
| Vertex Pharmaceutical | Rheumatoid arthritis | VX11-509-102 |
| Thrombosis Research Institute | Other | TRI08888-GARFILED |
| Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-303 |
| Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-301 |
| Boehringer Ingelheim | Type 2 diabetes | BI 1245.25 |
| Eli Lilly and Compary | Type 2 diabetes | 108440 |
| Eli Lilly and Compary | Type 2 diabetes | 108440 |
| ChemoCentryx Inc. | Diabetes/diabetic nephropathy | CL005_140 |
| GlaxoSmithKline Kft. | COPD | HZC113782 |
| Adiposs | Healthy | ImageBAT |
| MITOCHON PHARMACEUTICALS | Central Nervous System | MTC - 001 |
| Takeda Global Research | Hepatic Impairment | TAK-994-1013 |
| BioVersys AG | Healthy | BV-100_DDI |
| Angelini Pharma S.p.A. | Low Back Pain | 147(Z)WO20157 |
| Motorpharmacology | Healthy | MTP_001 |
| Astrocytes Pharmaceuticals Inc. | Healthy | AST-004-101-102 |
| Akston Biosciences Corp. | COVID-19 | 900452-CT-21-001 |
| Eli Lilly and Compary | Rheumatoid arthritis | I4V-MC-JAJG |
| Basic Pharma Technologies | Impetigo | IMPET |
| Chronolife SAS | Other cardiovascular | CLIN-PREDIGMA-001 |
| resTORbio Inc. | Hepatic Impairment | RTB101 |
| AbbVie Inc. | Colitis Ulcerosa | M16-066 |
| Institut de Recherches Internationales SERVIER (I.R.I.S.) | Chronic Venous Disease | CL3-05682-109 |
| Cirius Therapeutics, Inc. | Diabetes/ obesity in diabetes | CTI-0602K-C013 |
| AbbVie Inc. | Colitis Ulcerosa | M16-066 |
| Urovant Sciences GmbH | Overactive bladder | RVT-901-3004 |
| Celgene International II Sàrl | Crohn Disease | RPC01-3204 |
| Celgene International II Sàrl | Crohn Disease | RPC01-3203 |
| Zeno Pharmaceuticals Inc. | Non Small Cell Lung Cancer | ZN-e4-001 |
| AbbVie Inc. | Colitis Ulcerosa | M16-067 |
| Urovant Sciences GmbH | Overactive bladder | RVT-901-3003 |
| Gilead Sciences Inc. | Rheumatoid arthritis | GS-US-417-0303 |
| Gilead Sciences Inc. | Rheumatoid arthritis | GS-US-417-0302 |
| UCB Pharma Ltd | SPA | AS0006 |
| AbbVie Inc. | Rheumatoid arthritis | JAKMTXIR2 |
| Sun Pharmaceutical | Other | CLR_15_02 |
| Incyte Corporation | Non Small Cell Lung Cancer | INCB 39110-205 |
| Ignyta Pharma | Non Small Cell Lung Cancer | RXDX-101-02 |
| Actavis Group PTC | Asthma | ACT-2014-075 |
| Boehringer Ingelheim | Non Small Cell Lung Cancer | 1381,2 |
